Posfrea
Product Images NDC 83831-104

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Posfrea (NDC 83831-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 01)

Chemical structure of the active ingredient shown with a hydrochloride (HCl) salt, associated with posfrea 0.25 mg/5 mL by Avyxa Pharma, LLC.*

FDA Label Image

Posfrea (palonosetron) Injection, 0.25mg/5 mL -container Label (31e6e672 Bc75 4bb0 88ea Fdb864aff275 02)

Label for Posfrea (palonosetron) Injection 0.25 mg/5 mL (0.05 mg/mL) single-dose vial. The label includes storage instructions, manufacturer information (Avyxa Pharma, LLC), NDC 83831-105-01, and indicates the product is made in India. It is for intravenous use.*

FDA Label Image

Posfrea (palonosetron) Injection, 0.25mg/5 mL -carton Label (31e6e672 Bc75 4bb0 88ea Fdb864aff275 03)

Posfrea (palonosetron) Injection 0.25 mg/5 mL (0.05 mg/mL) is shown in a flat carton packaging label manufactured for Avyxa Pharma, LLC. The label includes dosage form as a 5 mL single dose vial for intravenous use. The color scheme incorporates black text with a blue highlight on dosage and a red-orange wave design near the bottom. Storage information and active ingredient contents are detailed on the label. The labeler logo and barcode are present.*

FDA Label Image

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 113 1)

FDA Label Image

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 66 2)

A chart illustrating the difference in complete response rates, displayed as point estimates with error bars representing confidence intervals. The horizontal axis shows the difference in response rates (%) ranging from -10 to 35, and the vertical axis categorizes different unspecified treatment groups or measures with intervals marked such as [2%, 23%], [-2%, 22%], and [-9%, 13%].*

FDA Label Image

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 68 2)

A bar graph comparing difference in complete response rates between two groups, with percentages labeled as 30% and 27% respectively on the bars. The x-axis shows difference in complete response rates ranging from -10 to 35.*

FDA Label Image

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 70 2)

A small horizontal bar graph illustrating the difference in complete response rates, with two data points showing approximate percentages at 7% and 31%, and 0% and 24%, respectively. The x-axis ranges from -10 to 35 percent difference.*

FDA Label Image

Image (31e6e672 Bc75 4bb0 88ea Fdb864aff275 86 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.